Two Sigma Securities’s Evogene EVGN Stock Holding History

Two Sigma Securities’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.6K	Buy	+12,465	New	+$11.8K	﹤0.01%	1468
2025 Q4	–	Sell	-11,406	Closed	-$13K	–	1629
2025 Q3	$13K	Sell	11,406 -9,683	-46%	-$12.3K	﹤0.01%	1186
2025 Q2	$27K	Buy	21,089 +7,527	+56%	+$9.21K	﹤0.01%	1168
2025 Q1	$17K	Buy	13,562 +2,403	+22%	+$3.62K	﹤0.01%	1133
2024 Q4	$20.9K	Buy	+11,159	New	+$22K	﹤0.01%	1309
2024 Q3	–	Sell	-1,315	Closed	-$8.55K	–	3074
2024 Q2	$8.55K	Buy	+1,315	New	+$9.18K	﹤0.01%	2824
2024 Q1	–	Sell	-1,237	Closed	-$10.4K	–	3130
2023 Q4	$10.4K	Sell	1,237 -232	-16%	-$1.46K	﹤0.01%	2812
2023 Q3	$8.62K	Buy	1,469 +373	+34%	+$3.27K	﹤0.01%	2718
2023 Q2	$11.7K	Buy	+1,096	New	+$7.41K	﹤0.01%	2574
2022 Q3	–	Sell	-1,025	Closed	-$8K	–	2738
2022 Q2	$8K	Buy	+1,025	New	+$10K	﹤0.01%	2074

Other funds holding EVGN

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

TCM

Tradewinds Capital Management Bellingham, Washington $504M AUM 40.92% 1-Year Est. Return

Two Sigma Securities's EVGN Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Evogene (EVGN) in Q1 2026: 12,465 shares worth $9.6K. The stake represents ﹤0.01% of the portfolio and ranks #1468 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in EVGN as recently as Q3 2025.

Two Sigma Securities first reported a position in EVGN in Q2 2022 and has held it in 10 quarters since. The position peaked at $27K in Q2 2025. 15 funds tracked by Wall St. Rank hold EVGN as of Q1 2026.

Two Sigma Securities held 12,465 shares of Evogene worth $9.6K as of Q1 2026.
Evogene was a new Two Sigma Securities position in Q1 2026.
Evogene made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1468 holding.
Two Sigma Securities first reported a position in Evogene in Q2 2022 and has held it in 10 quarters since.
Two Sigma Securities's Evogene position peaked at $27K in Q2 2025.
15 funds tracked by Wall St. Rank held Evogene as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.